Custom Peptide Libraries

With our proprietary parallel synthesis technology, Mimotopes can synthesise hundreds of peptides simultaneously, thereby massively reducing the price and time to delivery.

High quality Peptide Libraries at affordable prices

30 Years Experience

Mimotopes is the founder of peptide library technology. We continued to grow and learn over the decades – now our expertise is unrivaled.

We work tirelessly to stay ahead of the game to ensure, as always, that we supply the best possible products.

Efficient & Economical Screening Solutions

Peptide Libraries have dozens of potential applications. From screening to epitope mapping, a peptide library can be exclusively designed to your specifications, for your research.

  • Discover crucial residues with an Alanine Scan Library
  • Map epitopes with an Overlapping Library
  • Narrow down the shortest active sequences with a Truncated Library

Dozens of Options to Customise

A standard Peptide Library can be supplied as with a precise length and offset designed to best suit your assays, but that’s not all. Modifications and labels can be applied to the termini or even within the sequence. Arrange a consultation to discuss your options and design your library.

Contact us today for your free quote! 

Phone: +61 3 9565 1111
Fax: +61 3 9565 1199 
Email: mimotopes@mimotopes.com

Go to article: Home | US excess vs. global accessGo to article: EditorialGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: ContentsGo to article: ELPRO Monitoring SolutionsGo to article: NewsGo to article: BaxterGo to article: The pharma industry briefingGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: Turning pharma green: an eco-wish list for the industryGo to article: Scandinavian Health Company InsightGo to article: Scandinavian HealthGo to article: Q&A: disrupting DNA synthesis with Twist’s Emily LeproustGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: Tips and tricks for regulating advanced therapiesGo to article: Gerteis Company InsightGo to article: GerteisGo to article: Lyme disease: what's actually going on here?Go to article: Subcuject Company Insight Go to article: SubcujectGo to article: The US and the developing world: a tale of two opioid crises Go to article: KugelmeiersGo to article: Tracking priority medicines in transit: UPS launches tech-enabled serviceGo to article: Modality SolutionsGo to article: When deadlines turn deadly: examining the psychology of drug regulatorsGo to article: Zenatek Go to article: Proteus Digital Health: a sharp lesson for smart pills?Go to article: MimotopesGo to article: Deals in brief powered by GlobalDataGo to article: MicronovaGo to article: The key list powered by GlobalDataGo to article: EmisphereGo to article: Markets and Indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: Air FranceGo to article: EventsGo to article: ILC Dover Go to article: Next issue